Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,422,748
  • Shares Outstanding, K 46,810
  • Annual Sales, $ 1,361 M
  • Annual Income, $ 167,680 K
  • EBIT $ 277 M
  • EBITDA $ 407 M
  • 60-Month Beta 0.43
  • Price/Sales 2.47
  • Price/Cash Flow 9.95
  • Price/Book 4.07

Options Overview Details

View History
  • Implied Volatility 36.35% ( -3.62%)
  • Historical Volatility 82.52%
  • IV Percentile 22%
  • IV Rank 22.20%
  • IV High 72.27% on 10/21/25
  • IV Low 26.10% on 11/15/24
  • Put/Call Vol Ratio 0.07
  • Today's Volume 526
  • Volume Avg (30-Day) 543
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 8,092
  • Open Int (30-Day) 7,371

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.27
  • Number of Estimates 5
  • High Estimate 1.28
  • Low Estimate 1.26
  • Prior Year 1.19
  • Growth Rate Est. (year over year) +6.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.55 +52.23%
on 10/15/25
74.98 -1.43%
on 11/13/25
+23.67 (+47.11%)
since 10/13/25
3-Month
47.31 +56.21%
on 09/26/25
74.98 -1.43%
on 11/13/25
+20.03 (+37.18%)
since 08/13/25
52-Week
47.31 +56.21%
on 09/26/25
92.54 -20.13%
on 11/14/24
-17.87 (-19.47%)
since 11/13/24

Most Recent Stories

More News
5 Insightful Analyst Questions From Haemonetics’s Q3 Earnings Call

5 Insightful Analyst Questions From Haemonetics’s Q3 Earnings Call

HAE : 73.91 (+1.08%)
HAE Q3 Deep Dive: Margin Expansion and Portfolio Rationalization Drive Outperformance

HAE Q3 Deep Dive: Margin Expansion and Portfolio Rationalization Drive Outperformance

HAE : 73.91 (+1.08%)
Why Are Haemonetics (HAE) Shares Soaring Today

Why Are Haemonetics (HAE) Shares Soaring Today

HAE : 73.91 (+1.08%)
Haemonetics (NYSE:HAE) Delivers Impressive Q3, Stock Jumps 12.8%

Haemonetics (NYSE:HAE) Delivers Impressive Q3, Stock Jumps 12.8%

HAE : 73.91 (+1.08%)
Haemonetics: Fiscal Q2 Earnings Snapshot

Haemonetics: Fiscal Q2 Earnings Snapshot

HAE : 73.91 (+1.08%)
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Financial release and supplemental presentation accessible online

HAE : 73.91 (+1.08%)
What To Expect From Haemonetics’s (HAE) Q3 Earnings

What To Expect From Haemonetics’s (HAE) Q3 Earnings

HAE : 73.91 (+1.08%)
3 Russell 2000 Stocks We Think Twice About

3 Russell 2000 Stocks We Think Twice About

BLMN : 6.79 (+4.62%)
AZTA : 29.88 (-2.89%)
HAE : 73.91 (+1.08%)
Haemonetics (HAE): Buy, Sell, or Hold Post Q2 Earnings?

Haemonetics (HAE): Buy, Sell, or Hold Post Q2 Earnings?

HAE : 73.91 (+1.08%)
3 Healthcare Stocks We Find Risky

3 Healthcare Stocks We Find Risky

UFPT : 234.30 (-1.26%)
HAE : 73.91 (+1.08%)
AORT : 45.59 (-4.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Relative Strength is above 80%. The market is in extreme overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood...

See More

Key Turning Points

3rd Resistance Point 76.57
2nd Resistance Point 75.78
1st Resistance Point 74.84
Last Price 73.91
1st Support Level 73.11
2nd Support Level 72.32
3rd Support Level 71.38

See More

52-Week High 92.54
Fibonacci 61.8% 75.26
Last Price 73.91
Fibonacci 50% 69.93
Fibonacci 38.2% 64.59
52-Week Low 47.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar